PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.\', \'Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.\', \'Department of Immunology, University Hospital Zurich (USZ), Zurich, Switzerland.\', \'Institute for Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.\', \'Clinic for Internal Medicine, Uster Hospital, Uster, Switzerland.\', \'Department of Medicine, Limmattal Hospital, Schlieren, Switzerland.\', \'Clinic for Internal Medicine, City Hospital Triemli Zurich, Zurich, Switzerland.\', \'Department of Internal Medicine, University Hospital Zurich (USZ), Zurich, Switzerland.\', \'Faculty of Medicine, University of Zurich, Zurich, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1016/j.xcrm.2020.100166
?:hasPublicationType
?:journal
  • Cell reports. Medicine
is ?:pmid of
?:pmid
?:pmid
  • 33521697
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • A distinct innate immune signature marks progression from mild to severe COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all